ROWE COMPANIES·4

Oct 14, 10:39 AM ET

MORPHIS GENE S 4

4 · ROWE COMPANIES · Filed Oct 14, 2003

Insider Transaction Report

Form 4
Period: 2003-10-14
MORPHIS GENE S
Chief Financial Officer
Transactions
  • Award

    Option to purchase

    2002-12-03+1,33423,000 total
    Exercise: $2.15From: 2002-12-03Exp: 2012-12-03common (1,334 underlying)
  • Award

    Common Stock

    2003-10-14$3.00/sh2,100$6,30018,000 total
  • Award

    Common Stock

    2003-10-13$2.93/sh+900$2,63715,900 total
  • Award

    Option to purchase

    2002-12-03+1,33323,000 total
    Exercise: $2.15From: 2003-12-03Exp: 2012-12-03common (1,333 underlying)
  • Award

    Option to purchase

    2002-07-30+5,00023,000 total
    Exercise: $1.95From: 2002-07-30Exp: 2012-07-30common (5,000 underlying)

Documents

1 file
  • 4
    rrd20295.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP